NPI: 1396837951 · DES MOINES, IA 50309 · Ambulance · NPI assigned 09/29/2006
Authorized official ALLEN, PATRICIA controls 18+ related entities in our dataset. Read more
| Authorized Official | ALLEN, PATRICIA (CFO) |
| NPI Enumeration Date | 09/29/2006 |
Other providers sharing the same authorized official: ALLEN, PATRICIA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 78,174 | $6.43M |
| 2019 | 78,750 | $6.47M |
| 2020 | 63,116 | $4.95M |
| 2021 | 110,854 | $9.80M |
| 2022 | 146,024 | $12.61M |
| 2023 | 137,568 | $10.93M |
| 2024 | 77,560 | $6.88M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 58,762 | 56,311 | $17.24M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 103,996 | 98,213 | $11.45M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 26,732 | 25,216 | $10.43M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 30,765 | 29,662 | $5.79M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 138,325 | 132,093 | $1.88M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 11,553 | 10,742 | $1.72M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 4,148 | 4,034 | $1.36M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 15,026 | 14,542 | $700K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1,492 | 728 | $672K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 8,212 | 7,981 | $618K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,323 | 4,185 | $518K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 9,587 | 3,812 | $506K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6,198 | 6,054 | $468K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 6,827 | 6,394 | $467K |
| J0485 | Injection, belatacept, 1 mg | 964 | 664 | $425K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,665 | 4,260 | $314K |
| S9455 | Diabetic management program, group session | 2,486 | 2,209 | $311K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 962 | 877 | $286K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 4,409 | 1,659 | $272K |
| 90461 | 6,799 | 6,573 | $249K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3,408 | 3,307 | $226K |
| 59025 | Fetal non-stress test | 1,719 | 1,559 | $214K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 3,939 | 3,666 | $185K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 282 | 278 | $182K |
| 90670 | 2,688 | 2,628 | $113K | |
| 64615 | 716 | 615 | $113K | |
| 95813 | 511 | 443 | $113K | |
| 71046 | Radiologic examination, chest; 2 views | 1,642 | 1,550 | $103K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,456 | 2,243 | $92K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,052 | 697 | $84K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 11,154 | 10,884 | $84K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 561 | 543 | $63K |
| 90686 | 7,397 | 7,192 | $62K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 680 | 670 | $57K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 44,351 | 40,914 | $49K |
| 97597 | 561 | 381 | $47K | |
| 80053 | Comprehensive metabolic panel | 24,042 | 21,980 | $46K |
| 96127 | 10,983 | 10,227 | $45K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 196 | 187 | $34K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 637 | 632 | $34K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 11,144 | 10,036 | $33K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,376 | 531 | $32K |
| 94060 | 110 | 108 | $31K | |
| 93296 | 1,492 | 1,414 | $29K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 273 | 269 | $25K |
| 90723 | 1,033 | 1,020 | $19K | |
| 0072A | 515 | 512 | $19K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 180 | 140 | $18K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 134 | 134 | $18K |
| 0071A | 461 | 459 | $16K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 131 | 127 | $15K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 83 | 82 | $15K |
| 91200 | 121 | 115 | $13K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 81 | 75 | $12K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 353 | 142 | $11K |
| 94010 | 2,567 | 2,483 | $11K | |
| 97803 | 552 | 508 | $10K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 398 | 141 | $10K |
| 91321 | 113 | 112 | $9K | |
| 70450 | Computed tomography, head or brain; without contrast material | 57 | 54 | $8K |
| 85046 | 1,422 | 1,311 | $7K | |
| 95913 | 20 | 17 | $7K | |
| 90651 | 91 | 88 | $7K | |
| 36415 | Collection of venous blood by venipuncture | 46,421 | 40,481 | $6K |
| 82728 | 445 | 402 | $5K | |
| 83690 | 4,932 | 4,623 | $5K | |
| 81001 | 16,584 | 15,529 | $5K | |
| 71045 | Radiologic examination, chest; single view | 94 | 91 | $5K |
| 92523 | 30 | 30 | $5K | |
| 92526 | 63 | 45 | $4K | |
| 90677 | 125 | 123 | $4K | |
| 94762 | 30 | 26 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,775 | 2,594 | $4K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,353 | 2,190 | $3K |
| 97802 | 61 | 55 | $2K | |
| 81025 | 1,486 | 1,432 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,380 | 1,303 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 164 | 155 | $1K |
| 0154A | 49 | 35 | $1K | |
| 29581 | 25 | 14 | $1K | |
| 93017 | 57 | 52 | $1K | |
| 0082A | 41 | 29 | $1K | |
| 91322 | 12 | 12 | $1K | |
| 90672 | 153 | 144 | $939.55 | |
| G0008 | Administration of influenza virus vaccine | 31 | 28 | $937.18 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 62 | 55 | $887.12 |
| 99173 | 608 | 598 | $763.39 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 5,171 | 4,783 | $593.26 |
| 90697 | 195 | 185 | $576.89 | |
| 0074A | 21 | 14 | $560.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 15 | 14 | $542.76 |
| J2704 | Injection, propofol, 10 mg | 86 | 82 | $518.51 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 456 | 405 | $332.90 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 913 | 833 | $279.21 |
| 90734 | 12 | 12 | $273.39 | |
| 99177 | 447 | 441 | $257.92 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 302 | 269 | $232.77 |
| J3490 | Unclassified drugs | 47 | 41 | $221.94 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 471 | 458 | $219.80 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 42 | 41 | $125.00 |
| 85652 | 54 | 51 | $123.71 | |
| 69210 | 17 | 16 | $111.88 | |
| 83550 | 17 | 13 | $107.90 | |
| 83735 | 912 | 850 | $105.84 | |
| 74019 | 391 | 378 | $103.43 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 13 | 12 | $88.99 |
| 83540 | 17 | 13 | $79.95 | |
| 84100 | 16 | 12 | $72.86 | |
| 84484 | 3,343 | 2,249 | $69.91 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 434 | 413 | $69.08 |
| 82962 | 192 | 104 | $40.56 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 184 | 169 | $35.15 |
| 83605 | 154 | 129 | $31.54 | |
| 85027 | 342 | 318 | $30.33 | |
| 81003 | 556 | 514 | $22.42 | |
| 87510 | 73 | 65 | $19.05 | |
| 87480 | 73 | 65 | $19.05 | |
| 87660 | 73 | 65 | $19.05 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 516 | 471 | $17.78 |
| 82077 | 27 | 25 | $16.41 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 28 | 28 | $15.72 |
| 87081 | 325 | 318 | $13.94 | |
| 80047 | 456 | 433 | $13.71 | |
| 87430 | 620 | 599 | $10.40 | |
| 85610 | 73 | 68 | $8.16 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 24 | 16 | $4.89 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 14 | 13 | $3.43 |
| 85014 | 453 | 433 | $2.93 | |
| 95886 | 258 | 251 | $0.00 | |
| 90680 | 1,135 | 1,116 | $0.00 | |
| 95012 | 711 | 692 | $0.00 | |
| 90647 | 1,123 | 1,104 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 189 | 178 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 724 | 360 | $0.00 |
| 86850 | 16 | 13 | $0.00 | |
| 87486 | 71 | 67 | $0.00 | |
| 96376 | 78 | 60 | $0.00 | |
| 86140 | 144 | 137 | $0.00 | |
| 82657 | 119 | 66 | $0.00 | |
| 0352U | 65 | 59 | $0.00 | |
| G0378 | Hospital observation service, per hour | 388 | 367 | $0.00 |
| 91315 | 31 | 31 | $0.00 | |
| 99153 | Mod sedat endo service >5yrs | 96 | 89 | $0.00 |
| 87581 | 71 | 67 | $0.00 | |
| 90716 | 12 | 12 | $0.00 | |
| 84703 | 14 | 14 | $0.00 | |
| 85730 | 14 | 14 | $0.00 | |
| 87040 | 13 | 12 | $0.00 | |
| 86901 | 17 | 14 | $0.00 | |
| 85018 | 13 | 12 | $0.00 | |
| 90696 | 25 | 24 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 27 | 24 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 470 | 423 | $0.00 |
| C1729 | Catheter, drainage | 218 | 190 | $0.00 |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 105 | 96 | $0.00 |
| 90710 | 26 | 25 | $0.00 | |
| 90633 | 581 | 564 | $0.00 | |
| 90473 | 29 | 26 | $0.00 | |
| A4617 | Mouth piece | 402 | 397 | $0.00 |
| 87400 | 889 | 426 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 124 | 116 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 112 | 67 | $0.00 |
| 84702 | 16 | 12 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 14 | 13 | $0.00 |
| 80076 | 81 | 78 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 27 | 24 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 71 | 67 | $0.00 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 14 | 14 | $0.00 |
| 90700 | 27 | 26 | $0.00 | |
| 86900 | 17 | 14 | $0.00 |